AMPE

Ampio Pharmaceuticals Inc (AMPE) | Rumor.io

Ampio Pharmaceuticals

AMPE

Attention (50-day avg)0%

Attention rank (50-day avg)#4,862

Bullish sentiment (50-day avg)0%

Price to earnings ratio0

Market capitalization207.9K

Earnings per share-12.8

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-8.6M

Social

What share of all stock conversation is about AMPE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Mar 27

$AMPE trading at $0.78, sparking questions about its value.
Users are still watching $AMPE, awaiting potential developments.
No specific information or insights are provided about $AMPE.

Generated by AI

Sentiment

Of the messages about AMPE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	0%	0%	33.33% +26.67
Bearish	100%	100%	100%	66.67% -26.67

Bullish· Jan 10

Ampio Pharmaceuticals, Inc. ($AMPE) has a tiny float of only 807k shares, which could lead to a significant price pop.
The company has a history of breakouts on its chart and has a previous high of $7.47, which could be a target for the stock.
With a 10% short interest and a strong daily chart, $AMPE is setting up for a potential multi-bagger run, with analysts even setting a $70 price target for a similar pharma company.

Bearish· Jan 10

The stock has a low float, similar to $NEXI, but failed to move up despite a comparable float.
The stock's price movement is unpredictable and prone to sharp declines, making it a "hopeless play".
The stock's price action is likely the result of a pump and dump scheme, with the price being manipulated by individuals who buy and sell quickly to profit from the volatility.

Generated by AI

Topics

Of the messages about AMPE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	97.67%
Controversies	—	—	—	2.33%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Mar 26

Ampio Pharmaceuticals, Inc. (AMPE) announces voluntary delisting and SEC deregistration to terminate and suspend reporting obligations.
The delisting is expected to become effective on or about April 14, 2024.
The company has outstanding shares of less than 1 million.

Controversies· Sep 9

*Ampio Pharmaceuticals, Inc. (AMPE) is facing a securities class action lawsuit, with investors encouraged to seek counsel before the looming deadline.*
*Several law firms, including Rosen Law Firm and Glancy Prongay & Murray LLP, are reminding investors of the deadline to join the class action lawsuit against AMPE.*
*Investors who have suffered losses of $100,000 or more are being encouraged to contact the Schall Law Firm to discuss potential legal action against AMPE.*

Technical Analysis· Jul 24

$AMPE has formed a double top on the hourly chart, which could be a sign of a reversal, but a close above 1.07 would be very bullish.
The daily chart shows a beautiful setup, with a potential pullback to.95 before making the next leg up over a dollar.
The RSI is getting hot, and the 5-min chart shows a bull flag, but the resistance at 0.98 is very strong, and the stock is retracing after a new 52wk high.

Generated by AI

Community

Of the messages about AMPE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	12.68%
Newcomers	100%	100%	100%	87.32%

Regulars· Mar 26

$AMPE is being watched by regulars due to its trending stock status on March 26, 2024.
Regulars are focusing on Ampio Pharmaceuticals Inc. due to its recent performance.
Ampio Pharmaceuticals, Inc. is experiencing downside momentum according to recent data.

Newcomers· Jan 10

Many newcomers are focusing on the potential for Ampio Pharmaceuticals ($AMPE) to experience a short squeeze due to its low float of 832,000 shares outstanding, which could lead to a significant price increase.
New investors are also highlighting the company's upcoming offering, which expires on January 20, and the potential for a pump in the stock price if the offering is successful.
Some newcomers are calling for a price target of $4.75, citing the stock's recent volatility and the potential for a large breakout spike, with some even achieving a 45% price increase in a short period of time.

Generated by AI

Also Discussed

Investors talking about AMPE also mention

#	Name	Attention
1	vTv Therapeutics Inc. Class A Common StockVTVT	0%new
2	Can-Fite BioPharma Ltd. ADRCANF	0%0
3	BLPH - Bellerophon Therapeutics, Inc.	——
4	Rockwell Medical Inc.RMTI	0%new
5	RGLS - Regulus Therapeutics Inc.	——
6	XOMA CorporationXOMA	0%0
7	CorMedix Inc.CRMD	0%+0
8	Galectin Therapeutics Inc.GALT	0.01%+0.01
9	Kite Realty Group TrustKRG	0%0
10	Flexion Therapeutics, Inc.FLXN	0%0